(Q36055380)

11 August 2017

Population PK and PK/PD modelling of microencapsulated octreotide acetate in healthy subjects (English)

1 reference

11 August 2017

1 reference

H Zhou

1

1 reference

11 August 2017

T L Chen

2

1 reference

11 August 2017

M Marino

3

1 reference

11 August 2017

H Lau

4

1 reference

11 August 2017

T Miller

5

1 reference

11 August 2017

G Kalafsky

6

1 reference

11 August 2017

J F McLeod

7

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

British Journal of Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

50

1 reference

11 August 2017

6

1 reference

11 August 2017

543-552

1 reference

Pharmacokinetics, pharmacodynamics, and safety of microencapsulated octreotide acetate in healthy subjects

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015017

Sandostatin LAR in acromegalic patients: long-term treatment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015017

Growth hormone and diabetes mellitus. A review of sixty-three years of medical research and a glimpse into the future?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015017

Clinical pharmacokinetics of octreotide. Therapeutic applications in patients with pituitary tumours.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015017

Octreotide, a new somatostatin analogue

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015017

Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015017

Somatostatin analogs: their role in the treatment of growth hormone hypersecretion and excessive body growth

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015017

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015017

Continuous subcutaneous octreotide infusion markedly suppresses IGF-I levels whilst only partially suppressing GH secretion in diabetics with retinopathy.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015017

The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015017

Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015017

Is insulinlike growth factor I associated with diabetic retinopathy?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015017

Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015017

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015017

Sandostatin LAR (microencapsulated octreotide acetate) in acromegaly: pharmacokinetic and pharmacodynamic relationships

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11136293

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11136293

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1046/J.1365-2125.2000.00297.X

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

11136293

1 reference